Activity of ciprofloxacin against urinary tract isolates
Peddie, B.A.; Bailey, R.R.
New Zealand Medical Journal 101(846): 276-277
1988
ISSN/ISBN: 0028-8446 PMID: 3374909 Document Number: 307731
Document emailed within 1 workday
Related Documents
Piccolomini, R.; Ravagnan, G. 1986: Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(4): 249-256García Victor, F.; Ferrero Doria, R. 2001: Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension Archivos Espanoles de Urologia 54(4): 313-320
Muratani, T.; Doi, K.; Kobayashi, T.; Nakamura, T.; Matsumoto, T. 2009: Antimicrobial activity of tebipenem against various clinical isolates from various specimen, mainly urinary tract Japanese Journal of Antibiotics 62(2): 116-126
Lin, C.-Y.; Huang, S.-H.; Chen, T.-C.; Lu, P.-L.; Lin, W.-R.; Chen, Y.-H. 2008: Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates Journal of Microbiology Immunology and Infection 41(4): 325-331
Martorana, G.; Giberti, C.; Pizzorno, R.; Bonamini, A.; Oneto, F.; Curotto, A.; Soro, O. 1988: Treatment of urinary tract infections with ciprofloxacin Clinical Therapeutics 10(5): 516-520
Klietmann, W.; Focht, J.; Nösner, K. 1987: Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates Arzneimittel-Forschung 37(6): 661-666
Naccari, F.; Salpietro, D.C.; De Sarro, A.; Masaracchio, A.; Barberi, I. 1998: Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI) Research Communications in Molecular Pathology and Pharmacology 99(2): 187-192
Usein, C-Romanita.; Damian, M.; Tatu-Chiţoiu, D.; Căpuşă, C.; Făgăraş, R.; Mircescu, G. 2003: Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections Roumanian Archives of Microbiology and Immunology 62(3-4): 137-154
Demir, M.; Cevahir, N.; Kaleli, I.; Yildirim, U.; Sahin, R.; Cevik Tepeli, E. 2008: Investigation of siderophore, total matrix protease and elastase activity in Pseudomonas aeruginosa isolates from lower respiratory tract and extra-respiratory tract samples Mikrobiyoloji Bulteni 42(2): 197-208
Gobernado, M.; Valdés, L.; Alós, J.I.; Garcia-Rey, C.; Dal-Ré, R.; García-de-Lomas, J. 2007: Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 20(2): 206-210
Ako-Nai, K.A.; Ebhodaghe, B.I.; Osho, P.; Adejuyigbe, E.; Adeyemi, F.M.; Kassim, O.O. 2014: Preponderance of bacterial isolates in urine of HIV-positive malaria-infected pregnant women with urinary tract infection Journal of Infection in Developing Countries 8(12): 1591-1600
Foroumadi, A.; Soltani, F. 2003: Antituberculosis agents. IX. in vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates Bollettino Chimico Farmaceutico 142(6): 248-250
Malhotra, V.L.; Khandpur, N.; Dass, A.; Mehta, G. 2008: Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi Journal of Communicable Diseases 40(4): 269-272
Esposito, S.; Galante, D.; Pennucci, C.; Barba, D.; Limauro, D.; Scioli, C. 1984: Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(3): 196-199
Tiengrim, S.; Phiboonbanakit, D.; Thunyaharn, S.; Tantisiriwat, W.; Santiwatanakul, S.; Susaengrat, W.; Srisurat, N.; Malithong, A.; Srisangchan, P.; Thamlikitkul, V. 2012: Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections Journal of the Medical Association of Thailand 95(Suppl 2): S6-17
Karunanayake, L.; Atukorala, S.D. 2004: Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin Ceylon Medical Journal 49(4): 137-138
Benigno, V.; Attardo, S.; Dolce, A.F.; Di Peri, S.; Boncori, R.; La Grutta, A. 1987: Urinary tract malformations. Symptomatology, delayed diagnosis and urinary tract infections La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 9(3): 315-320
Bala, M.; Ray, K.; Kumari, S. 2003: Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India Sexually Transmitted Diseases 30(6): 523-525
Chowdhry, S.; Pandhi, D.; Vidhani, S.; Bhalla, P.; Reddy, B.S.N. 2002: High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi International Journal of Std and Aids 13(8): 564-567
Asvanich, K.; Fugpholngam, V.; Srimuang, S.; Tanphaichitra, D. 1998: In vitro activity and clinical evaluation of cefixime in urinary tract infection Journal of the Medical Association of Thailand 81(4): 301-304